Showing results (291-300 of 322) with videos related to

Sort By:
Pageof 33
The Medical Journal of Australia|April 26, 2021
An electronic decision support-based complex intervention to improve management of cardiovascular risk in primary health care: a cluster randomised trial (INTEGRATE)Ruth Webster, Tim Usherwood, Rohina Joshi, et al.
NPJ Digital Medicine|September 23, 2020
A digital health intervention for cardiovascular disease management in primary care (CONNECT) randomized controlled trialJulie Redfern, Genevieve Coorey, John Mulley, et al.
The New England Journal of Medicine|June 10, 2008
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes, Anushka Patel, Stephen MacMahon, et al.
JAMA|August 31, 2024
Low-Dose Triple-Pill vs Standard-Care Protocols for Hypertension Treatment in Nigeria: A Randomized Clinical TrialDike B Ojji, Abdul Salam, Mahmoud U Sani, et al.
The Lancet. HIV|September 19, 2017
Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trialPedro Cahn, Richard Kaplan, Paul E Sax, et al.
Lancet (London, England)|February 14, 2017
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic reviewClara K Chow, Jay Thakkar, Alex Bennett, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 7, 2025
Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression StudyNatalie T Mills, Stevan Nikolin, Nick Glozier, et al.
Circulation|May 9, 2022
Text Messages to Improve Medication Adherence and Secondary Prevention After Acute Coronary Syndrome: The TEXTMEDS Randomized Clinical TrialClara K Chow, Harry Klimis, Aravinda Thiagalingam, et al.
Trials|October 24, 2023
The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorderOrli S Schwartz, Paul Amminger, Bernard T Baune, et al.
Trials|April 29, 2026
Optimizing metabolic management on integrase-based ART (OPTIMAR): study protocol for a 2 × 2 factorial, randomised, double-blind placebo-controlled trial to compare the addition of dapagliflozin versus placebo, and rosuvastatin plus ezetimibe versus pitavastatin, in people with HIV on integrase strand transfer inhibitor-based antiretroviral therapy with elevated metabolic riskPhyo Pyae Nyein, Hila Haskelberg, Marianne Martinello, et al.
Pageof 33